By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atossa Genetics, which filed for an initial public offering in February, disclosed in a regulatory filing that it had $1,500 in revenues and a net loss of $3.4 million for full-year 2011.

Revenue figures compare to none from 2010. Atossa had a net loss of $1.1 million for FY 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.